Niflumic Acid EP Impurity E
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

15871-46-2Niflumic Acid EP Impurity E

● In Stock

Catalogue No.:VE0025064
CAS No.:15871-46-2
Mol. Formula:C13H9F3N2O2
Mol. Weight:282.22 g/mol

Additional information on CAS 15871-46-2

Parent drug

Niflumic Acid

IUPAC Name

6-[[3-(Trifluoromethyl)phenyl]amino]pyridine-3-carboxylic acid

Pharmacopoeial Synonyms

N/A

Other Synonyms

6-[m-(Trifluoromethyl)anilino]nicotinic acid; 6-((3-(Trifluoromethyl)phenyl)amino)nicotinic acid

Smiles

FC(F)(F)C1=CC=CC(NC2=CC=C(C(O)=O)C=N2)=C1

InChI

InChI=1S/C13H9F3N2O2/c14-13(15, 16)9-2-1-3-10(6-9)18-11-5-4-8(7-17-11)12(19)20/h1-7H, (H, 17, 18)(H, 19, 20)

Description

Niflumic Acid EP Impurity E (CAS 15871-46-2) | also known as 6-[m-(Trifluoromethyl)anilino]nicotinic acid or 6-((3-(Trifluoromethyl)phenyl)amino)nicotinic acid | is a structurally characterized process-related impurity detected in niflumic acid manufacture. This aromatic nicotinic acid derivative exhibits increased lipophilicity from the trifluoromethyl-substituted aniline moiety and shows distinctive reversed-phase HPLC retention and LC-MS fragmentation consistent with anilino loss. Analytical control emphasizes validated chromatographic methods | retention time and mass confirmation | and assessment of hydrolytic stability. Routine monitoring of Impurity E supports accurate impurity profiling | specification setting and maintenance of API quality.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url